Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.

Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators.

Lancet. 2019 Aug 30. pii: S0140-6736(19)31887-2. doi: 10.1016/S0140-6736(19)31887-2. [Epub ahead of print]

PMID:
31484629
2.

Effects of Serelaxin in Patients with Acute Heart Failure.

Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.

N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

PMID:
31433919
3.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

PMID:
31272931
4.

[Improvement of outcomes in patients with recent acute coronary syndrome: the place of PCSK9 inhibitors. The Resolution of National Advisory Board].

Akhmedzhanov NM, Vezikova NN, Voevoda MI, Galyavich AS, Gurevich VS, Duplyakov DV, Ezhov MV, Karpov YA, Kashtalap VV, Konovalov GA, Smolenskaya OG, Yakovlev AN.

Kardiologiia. 2019 Jun 20;59(5S):58-64. doi: 10.18087/cardio.n308. Russian.

PMID:
31221076
5.

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.

Jukema JW, Szarek M, Zijlstra LE, de Silva HA, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Karpov Y, Moryusef A, Pordy R, Prieto JC, Roe MT, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

J Am Coll Cardiol. 2019 Sep 3;74(9):1167-1176. doi: 10.1016/j.jacc.2019.03.013. Epub 2019 Mar 18.

6.

High Electron Affinity Molecular Dopant CN6-CP for Efficient Organic Light-Emitting Diodes.

Liu Y, Nell B, Ortstein K, Wu Z, Karpov Y, Beryozkina T, Lenk S, Kiriy A, Leo K, Reineke S.

ACS Appl Mater Interfaces. 2019 Mar 27;11(12):11660-11666. doi: 10.1021/acsami.8b21865. Epub 2019 Mar 12.

PMID:
30810028
7.

Layer-by-Layer Assembly Enabled by the Anionic p-Dopant CN6-CP•-K+: a Route to Achieve Interfacial Doping of Organic Semiconductors.

Karpov Y, Kiriy N, Formanek P, Zessin J, Hambsch M, Mannsfeld SCB, Lissel F, Beryozkina T, Bakulev V, Voit B, Kiriy A.

ACS Appl Mater Interfaces. 2019 Jan 30;11(4):4159-4168. doi: 10.1021/acsami.8b15033. Epub 2019 Jan 15.

PMID:
30608639
8.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.

N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.

PMID:
30415628
9.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
10.

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.

Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators.

N Engl J Med. 2018 Oct 4;379(14):1332-1342. doi: 10.1056/NEJMoa1808848. Epub 2018 Aug 27.

11.

Conjugated Polymers as a New Class of Dual-Mode Matrices for MALDI Mass Spectrometry and Imaging.

Horatz K, Giampà M, Karpov Y, Sahre K, Bednarz H, Kiriy A, Voit B, Niehaus K, Hadjichristidis N, Michels DL, Lissel F.

J Am Chem Soc. 2018 Sep 12;140(36):11416-11423. doi: 10.1021/jacs.8b06637. Epub 2018 Aug 28.

PMID:
30089208
12.

[Long-Term Statin Adherence in Patients with Stable Angina after Coronary Stenting].

Tomilova DI, Karpov YA, Lopukhova VV.

Kardiologiia. 2018 May;(5):65-71. Russian.

PMID:
29870326
13.

Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).

Danchin N, Almahmeed W, Al-Rasadi K, Azuri J, Berrah A, Cuneo CA, Karpov Y, Kaul U, Kayıkçıoğlu M, Mitchenko O, Ruiz AJ, Aguilar Salinas CA, Santos RD, Mercier F, Blom D; ICLPS Investigators.

Eur J Prev Cardiol. 2018 Jul;25(10):1087-1094. doi: 10.1177/2047487318777079. Epub 2018 May 17.

14.

Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study).

Glezer M, Vasyuk Y, Karpov Y.

Adv Ther. 2018 Mar;35(3):341-352. doi: 10.1007/s12325-018-0681-5. Epub 2018 Mar 5.

15.

Hexacyano-[3]-radialene anion-radical salts: a promising family of highly soluble p-dopants.

Karpov Y, Kiriy N, Al-Hussein M, Hambsch M, Beryozkina T, Bakulev V, Mannsfeld SCB, Voit B, Kiriy A.

Chem Commun (Camb). 2018 Jan 2;54(3):307-310. doi: 10.1039/c7cc08671g.

PMID:
29239413
16.

Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.

Karpov YA; FORTISSIMO physicians.

Clin Drug Investig. 2017 Sep;37(9):889-890. doi: 10.1007/s40261-017-0551-y. No abstract available.

PMID:
28695534
17.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

18.

Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.

Ridker PM, Tardif JC, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C; SPIRE Investigators.

N Engl J Med. 2017 Apr 20;376(16):1517-1526. doi: 10.1056/NEJMoa1614062. Epub 2017 Mar 17.

19.

[Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis].

Krougly LB, Fomicheva OA, Karpov YA, Popkova TV, Novikova DS, Nasonov EL.

Kardiologiia. 2016 Jun;56(6):89-95. Review. Russian.

PMID:
28290854
20.

[The Prediction Model of Cardiovascular Events Among the Russian Population: Methodological Aspects].

Kontsevaya AV, Shalnova SA, Suvorova EI, Balanova YA, Evstifeeva SE, Imaeva AE, Kapustina AV, Deev AD, Karpov YA, Ostroumova OD, Ageev FT, Blinkov OS, Zinchuk IY, Repekto KA, Boytsov S A.

Kardiologiia. 2016 Dec;56(12):54-62. Russian.

PMID:
28290805

Supplemental Content

Loading ...
Support Center